HomeCompareGFNCP vs PFE

GFNCP vs PFE: Dividend Comparison 2026

GFNCP yields 69.56% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GFNCP wins by $1.03M in total portfolio value
10 years
GFNCP
GFNCP
● Live price
69.56%
Share price
$101.21
Annual div
$70.40
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.08M
Annual income
$289,209.16
Full GFNCP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — GFNCP vs PFE

📍 GFNCP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGFNCPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GFNCP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GFNCP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GFNCP
Annual income on $10K today (after 15% tax)
$5,912.46/yr
After 10yr DRIP, annual income (after tax)
$245,827.79/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, GFNCP beats the other by $223,507.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GFNCP + PFE for your $10,000?

GFNCP: 50%PFE: 50%
100% PFE50/50100% GFNCP
Portfolio after 10yr
$566.3K
Annual income
$157,733.94/yr
Blended yield
27.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GFNCP
Analyst Ratings
3
Buy
1
Hold
Consensus: Buy
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GFNCP buys
0
PFE buys
0
No recent congressional trades found for GFNCP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGFNCPPFE
Forward yield69.56%6.13%
Annual dividend / share$70.40$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.3%13.2%
Portfolio after 10y$1.08M$49.6K
Annual income after 10y$289,209.16$26,258.71
Total dividends collected$925.0K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: GFNCP vs PFE ($10,000, DRIP)

YearGFNCP PortfolioGFNCP Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$17,677$6,976.70$9,153$693.39+$8.5KGFNCP
2$30,474$11,560.29$8,593$849.25+$21.9KGFNCP
3$51,289$18,681.81$8,336$1,066.78+$43.0KGFNCP
4$84,353$29,473.32$8,437$1,384.80+$75.9KGFNCP
5$135,696$45,437.98$9,013$1,875.40+$126.7KGFNCP
6$213,712$68,517.55$10,306$2,680.72+$203.4KGFNCP
7$329,825$101,153.70$12,820$4,101.38+$317.0KGFNCP
8$499,250$146,337.08$17,673$6,826.70+$481.6KGFNCP
9$741,835$207,637.47$27,543$12,591.86+$714.3KGFNCP
10$1,082,973$289,209.16$49,560$26,258.71+$1.03MGFNCP

GFNCP vs PFE: Complete Analysis 2026

GFNCPStock

General Finance Corporation, a specialty rental services company, provides portable storage, modular space, and liquid containment solutions in North America and the Asia-Pacific regions. The company's portable storage products include storage containers for classroom equipment storage, construction equipment and tool storage, disaster shelters, landscaping sheds, recreational equipment storage, and retail inventory storage applications; and freight containers used in freight transportation. Its modular space products comprise office or portable building containers, ground level offices, and modular buildings and offices for use in general administrative office spaces, military installations, workforce living accommodations, bank branches, classrooms/education, construction offices, day-care facilities, dormitories, general administrative office space, healthcare and rental facilities, retail space, and shelters. The company's liquid containment products consist of portable liquid storage tanks for well-site liquid containment needs, expansion/upgrade projects, highway construction/groundwater sewage, infrastructure projects, major industrial projects, mining pit pump works, municipal sewer and water projects, non-residential construction projects, pipeline construction and maintenance, and refinery turnarounds. It also provides steps, ramps, furniture, portable toilets, security systems, shelving, mud pumps, hoses, splitter valves, tee connectors, and other items used in connection with leased equipment. In addition, the company offers temporary prison holding cells, hoarding units, blast-resistant units, workforce living accommodations, temporary retail frontage units, and observatory units customized from storage containers, as well as shipping container modifications, specialty trailers and tanks, chassis, storm shelters, and trash hoppers. The company was founded in 2005 and is headquartered in Pasadena, California.

Full GFNCP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GFNCP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GFNCP vs SCHDGFNCP vs JEPIGFNCP vs OGFNCP vs KOGFNCP vs MAINGFNCP vs JNJGFNCP vs MRKGFNCP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.